Relmada Therapeutics Developing REL-1017 to Treat Major Depression
Depression affects hundreds of millions of people worldwide. Relmada Therapeutics is working to develop a treatment for those with depression […]
Read the post
Flatten the Curve: COVID-19
‘Flatten the Curve’ is sure to become a phrase forever linked with COVID-19. It refers to doing all we can […]
Read the post
Kazia’s Business Model
The path from idea to market in the oncology sector is long and expensive. In the traditional model of drug […]
Read the post
Brexit Passes
The European Union will include one less member on February 1st. The Withdrawal Agreement Bill completed its passage through Parliament […]
Read the post
Lower Drug Costs Claims
Just how how large is the difference between drug prices in the U.S. and Europe?
Read the post
Lower Drug Costs Stakeholders
What do stakeholders have to say about the Lower Drug Costs Now Act of 2019?
Read the post
Lower Drug Prices Overview
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), is a bill before the House that is intended to make prescription drugs more affordable for those in the Medicare program. The bill also seeks to maintain Medicare's future viability.
Read the post
Foodborne Illness
In effect, the power of the digital fingerprinting and related DNA sampling now in use in law enforcement can be put to work for foodborne illness outbreaks.
Read the post